Revenues - Schedule of Revenues From Product Sales Disaggregated by Customers (Details) - Revenues - Customer concentration risk |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| McKesson Corporation | ||||
| Disaggregation of Revenue [Line Items] | ||||
| Percentage | 46.00% | 31.00% | 47.00% | 35.00% |
| Cencora, Inc. | ||||
| Disaggregation of Revenue [Line Items] | ||||
| Percentage | 21.00% | 12.00% | 22.00% | 15.00% |
| Cardinal Health, Inc. | ||||
| Disaggregation of Revenue [Line Items] | ||||
| Percentage | 10.00% | |||
| Lilly | ||||
| Disaggregation of Revenue [Line Items] | ||||
| Percentage | 0.00% | 39.00% | 0.00% | 26.00% |
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|